Quarterly report pursuant to Section 13 or 15(d)

Segments (Tables)

v2.4.0.8
Segments (Tables)
6 Months Ended
Jun. 30, 2014
Segment Reporting [Abstract]  
Information regarding our geographic activities
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 
For the three months ended June 30,
 
For the six months ended June 30,
(In thousands)
2014
 
2013
 
2014
 
2013
Product revenues:
 
 
 
 
 
 
 
Pharmaceuticals
$
21,392

 
$
18,618

 
$
41,219

 
$
34,145

Diagnostics

 

 

 

Corporate

 

 

 

 
$
21,392

 
$
18,618

 
$
41,219

 
$
34,145

Revenue from services:
 
 
 
 
 
 
 
Pharmaceuticals
$

 
$

 
$

 
$

Diagnostics
2,093

 
3,108

 
4,003

 
6,160

Corporate
60

 
80

 
120

 
120

 
$
2,153

 
$
3,188

 
$
4,123

 
$
6,280

Revenue from transfer of intellectual property:
 
 
 
 
 
 
 
Pharmaceuticals
$

 
$
1,300

 
$
285

 
$
13,800

Diagnostics

 
715

 
191

 
972

Corporate

 

 

 

 
$

 
$
2,015

 
$
476

 
$
14,772

Operating (loss) income:
 
 
 
 
 
 
 
Pharmaceuticals
$
(20,368
)
 
$
(4,528
)
 
$
(36,941
)
 
$
3,955

Diagnostics
(6,805
)
 
(6,750
)
 
(13,882
)
 
(16,384
)
Corporate
(7,038
)
 
(5,762
)
 
(13,174
)
 
(10,787
)
Less: Operating loss attributable to noncontrolling interests
(674
)
 
(943
)
 
(1,163
)
 
(1,540
)
 
$
(34,885
)
 
$
(17,983
)
 
$
(65,160
)
 
$
(24,756
)
Depreciation and amortization:
 
 
 
 
 
 
 
Pharmaceuticals
$
2,287

 
$
1,702

 
$
4,135

 
$
3,397

Diagnostics
1,716

 
1,704

 
3,408

 
3,393

Corporate
24

 
45

 
48

 
90

 
$
4,027

 
$
3,451

 
$
7,591

 
$
6,880

Revenues:
 
 
 
 
 
 
 
United States
$
2,153

 
$
5,203

 
$
4,599

 
$
21,052

Chile
7,852

 
8,482

 
15,136

 
16,223

Spain
5,666

 
5,153

 
11,815

 
9,477

Israel
6,307

 
3,995

 
10,853

 
6,567

Mexico
1,546

 
988

 
3,377

 
1,878

Uruguay
21

 

 
38



 
$
23,545

 
$
23,821

 
$
45,818

 
$
55,197


(In thousands)
June 30,
2014
 
December 31,
2013
Assets:
 
 
 
Pharmaceuticals
$
1,059,635

 
$
1,065,033

Diagnostics
110,454

 
116,944

Corporate
156,993

 
209,539

 
$
1,327,082

 
$
1,391,516

Goodwill:

 

Pharmaceuticals
$
175,036

 
$
175,408

Diagnostics
50,965

 
50,965

Corporate

 

 
$
226,001

 
$
226,373